Designing dosing diaries that capture timing and reasons close to the dose, without pretending self-report tells the whole story
Medication adherence is one of the quiet variables that can shape a trial’s results. If participants are not taking the study drug as directed, the data on efficacy and safety becomes harder to interpret. Yet adherence is also one of the hardest things to measure well, especially once participants go home.
Phone and text dosing diaries are a practical way to collect adherence information between visits. This article covers what they can and cannot tell you, how to design check-ins around a regimen, and how to make the data useful once it reaches your study team.
Be honest about the limits of self-report
Let us start with the caveat. A dosing diary is self-report. Participants may forget, misremember, or tell you what they think you want to hear. No phone call or text message changes that basic fact, and any vendor who suggests otherwise is overselling.
So why use a diary at all? Because the value is not in proving adherence. The value is in timing and reasons, captured close to the dose. A participant who reports a missed dose the same evening, and says why, gives your team far more useful information than a participant trying to remember two weeks of doses at a site visit.
Pair diaries with other measures
A dosing diary works best as one input among several. Common companions include:
- Pill counts at site visits, which give a separate check against what participants report.
- Packaging data, where the study uses packaging that records when it was opened.
- Clinical data and drug levels, where the protocol collects them.
When diary entries are exported by patient ID, they can be joined with these other sources so your team can see where they agree and where they do not. A disagreement is not a failure. It is a signal worth a conversation with the participant.
Design the check-in around the regimen
The best dosing diary feels like it was built for that participant’s schedule, because it was.
Match the schedule
Once-daily regimens can use a single daily check-in. Twice-daily schedules may need two, timed around morning and evening doses. Some protocols call for doses tied to meals or other events. Set check-in times to fit, and let participants choose a time window that matches their routine where the protocol allows.
Keep questions short
A good adherence check-in can be just a few questions. Did you take your dose? About what time? If not, why? Short check-ins are easier to complete every day for months.
Ask about missed-dose reasons
When a participant reports a missed dose, ask why from a short list: forgot, felt unwell, ran out, side effects, traveling, or other. Reasons help sites respond. A participant who keeps running out has a supply problem. A participant who skips doses because of side effects may need a clinical follow-up.
Build in safety prompts
Adherence check-ins are a natural moment to ask whether anything has changed in how the participant feels. If a participant reports a possible adverse event, the system can send a prompt to the site so a coordinator can follow up. The site and investigator remain responsible for the clinical response.
Why phone and text
Many participants do well with an app. Others do not have a smartphone, do not want another app, or simply stop opening it. Phone and text reach people on the device they already use. An IVR call can ask the questions by voice and accept keypad answers. A text can serve as a reminder, or lead to a secure, authenticated portal so no protected health information is placed in the text itself.
Keeping participants engaged over the full study is about more than reminders. Our article on participant engagement that protects trial endpoints explores how to keep check-ins helpful rather than burdensome.
How IVR Lab supports adherence tracking
IVR Lab is a boutique firm that builds hyper-custom voice IVR, SMS, and secure messaging. In clinical trials, we provide patient-facing ePRO only: diaries, check-ins, reminders, adherence tracking, and adverse event prompts to the site. We do not handle randomization, kits, drug supply, or blinding. Those stay with the sponsor’s RTSM. Integration with your EDC or RTSM is scoped per study.
We build each check-in around the study’s regimen and export responses by patient ID so they can be joined with pill counts, packaging data, or other sources. For regulated studies, our regulated study mode uses frozen, SHA-256 fingerprinted survey versions and immutable responses, built around 21 CFR Part 11 expectations, with compliance confirmed by the sponsor’s validation. We are HIPAA compliant and SOC 2 audited, and Canadian data residency is available.
See how this works on our medication adherence and dosing diaries page, or learn more about our clinical trial ePRO services.

